Business Wire

RMS Global Catastrophe Model Leader Launches First Climate Change Models, Enabling New Risk Insights

Share

RMS, the world’s leading catastrophe risk modeling and solutions company, revealed that according to its new Climate Change Models, and based on today’s exposures, insured average annual losses (AAL) from North Atlantic Hurricane wind could increase by as much as 24 percent by 2050*, and European Flood risk AAL could increase by up to 59 percent by 2050**, based on no mitigating factors taken.

The new RMS Climate Change Models combine the RMS financial impact modeling framework with the best climate science consensus, including from the Intergovernmental Panel on Climate Change (IPCC). Generally available in June 2021, these models provide the most comprehensive climate change insights for North Atlantic Hurricane, Europe Inland Flood, and Europe Windstorm. Each model quantifies and differentiates the impacts of acute physical risk due to variable potential climate change scenarios (known as Representative Concentration Pathways or RCPs), different time horizons, and within specific regions. This means that organizations can make more informed decisions about the impact of climate change on different physical assets and portfolios, including residential and commercial properties, warehouses, and retail chains. Further climate change models and geographies will follow this initial model suite launch.

The new RMS Climate Change Models, data, and analytics empower boardrooms and organizations to:

  • Better understand the impacts climate change may have on capital, assets, pricing, and risk management today and in the future for acute physical risks
  • Price and manage risks to better reflect changing conditions
  • Confidently communicate acute physical risks posed by climate change to all stakeholders
  • Comply with regulatory submissions, such as Task Force on Climate-related Financial Disclosures (TCFD), Environmental, Social, and Governance (ESG), and Prudential Regulation Authority (PRA) reporting, in an efficient and sustainable way, as well as addressing future regulatory reporting requirements
  • Quantify climate risk impacts at any scale, from individual assets through to portfolios, commercial entities, sectors, and entire markets

Commenting on the RMS Climate Change Solutions, Tom Fink, senior vice president and managing director at Trepp, said: “Our clients in the banking and commercial real estate markets are working to quantify their exposure to environmental risks. By incorporating the RMS climate risks analytics, Trepp can better help the investment and financial services industry understand the physical risks posed by a changing climate.”

Speaking at the annual RMS Exceedance conference, RMS chief research officer, Robert Muir-Wood, said: “Unpacking the risks from climate change includes many individual perils, components, and situations, some of which are profoundly non-linear. Also, when mediated through tropical cyclone size, intensity and track, winter storms or major river floods, the relationship between climate parameters and their impacts becomes highly complex and can only be captured in a full catastrophe modeling capability that we are now delivering. Clear metrics on current and future climate perils, such as those available with the RMS Climate Change Models and Solutions, are becoming vital for the insurance industry, businesses, and investors globally. Increases in frequency and intensity of hurricanes, floods, and wildfires have already driven businesses, investors, and regulators to try to assess what this means for their current and future operations.”

RMS has been modeling natural catastrophe risk for the insurance industry for more than 30 years and has been leading research into the impact of climate change on catastrophe losses since its involvement in the 2007 4th IPCC Assessment Report. The RMS Climate Change Solutions also include climate change specialist advisory and consulting expertise as well as regulatory, ESG, and TCFD support.

Learn more about RMS Climate Change Solutions here: https://www.rms.com/climate-change

END

* For North Atlantic Hurricane the figures are for wind only and do not include storm surge or tropical cyclone-induced flooding. Exposure is based on the 2019 RMS Industry Exposure Database for all lines of business; further changes in losses would be expected from changes in exposure. The figures are based on an RCP 8.5 scenario.

** For European Flood, exposure is based on the 2020 RMS Industry Exposure Database for all lines of business; further changes in losses would be expected from changes in exposure. The figures are based on an RCP 8.5 scenario. 59 percent is based on the very latest version of the EU FL climate change model.

About RMS

Risk Management Solutions, Inc. (RMS) helps insurers, financial markets, corporations, and public agencies evaluate and manage global risk from natural and man-made catastrophes, including hurricanes, earthquakes, floods, climate change, cyber, and pandemics. RMS models underlie the ~$2 trillion Property & Casualty industry and the many insurers, reinsurers, and brokers around the world rely on RMS model science.

RMS helped pioneer the catastrophe risk industry, and continues to lead in innovation by marrying data and advanced model science with leading-edge SaaS technology. Leaders across multiple industries can address the risks of tomorrow with RMS Risk Intelligence™ (RI), our open, unified cloud platform for global risk, enabling them to tap into RMS HD models, rich data layers, intuitive applications, and APIs.

Further supporting the industry's transition to modern risk management, RMS spearheaded the Risk Data Open Standard (RDOS), a new modern open standard data schema designed to be an extensible, flexible, and future-proof asset within modeling/analysis systems.

RMS is a trusted solutions partner enabling effective risk management for better business decision making across risk identification and selection, mitigation, underwriting, and portfolio management.

Visit RMS.com to learn more and follow us on LinkedIn and Twitter.

(C) 2021 Risk Management Solutions, Inc. RMS, the RMS logo, and RMS Risk Intelligence are trademarks of Risk Management Solutions, Inc. All other trademarks are property of their respective owners.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

For More Information Contact:

Devonne Cusi (U.S.)
(U.K.) +1 551 226 1604
PRTeam@rms.com

Brian Norris, Cicero
+44 0 20 7947 5317
RMS@cicero-group.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

VRChat Partners With Anthos Capital to Close $80M Series D25.6.2021 17:00:00 EEST | Press release

VRChat, a social virtual reality (VR) platform that allows users to create, publish, and explore virtual worlds with other users around the globe, announced a Series D investment round of $80 million. The round was led by Anthos Capital, alongside participating investors Makers Fund, GFR Fund and others. VRChat is the leading social VR platform with millions of users, hundreds of thousands of worlds and over ten million unique avatars. It’s the top free VR application on both the Steam and Oculus Rift store, with over 40,000 concurrent users. Thanks to the creative freedom of VRChat’s tools, users have turned VRChat into a unique cultural phenomenon, tied closely to internet memes, events and culture. It has also become a virtual hangout for online events and communities. “VRChat hosts a vibrant, creative, and engaged community that has played a critical role in shaping its continued development. We’re excited to work with our investment partners to further grow and empower our communi

Incyte and MorphoSys Announce Positive CHMP Opinion for Tafasitamab in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma25.6.2021 14:42:00 EEST | Press release

Incyte (Nasdaq:INCY) and MorphoSys AG (FSE:MOR; NASDAQ:MOR) today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending the conditional marketing authorization of tafasitamab in combination with lenalidomide, followed by tafasitamab monotherapy, for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) who are not eligible for autologous stem cell transplantation (ASCT). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210625005231/en/ “The CHMP’s positive opinion of tafasitamab is a pivotal step towards addressing an urgent unmet medical need for the 30-40% of patients with relapsed or refractory DLBCL who do not respond to initial therapy or relapse thereafter,” said Steven Stein, M.D., Chief Medical Officer, Incyte. “Following the U.S. FDA’s approval of tafasitamab in July 2020, we eagerly aw

Advent Technologies Enters Into Definitive Agreement to Acquire the Fuel Cell Systems Businesses of fischer Group25.6.2021 13:45:00 EEST | Press release

Advent Technologies Holdings, Inc. (NASDAQ: ADN) ("Advent") today announced that it has entered into a definitive agreement to acquire the fuel cell systems businesses of fischer Group for an aggregate consideration of cash and stock of EUR52 million. These businesses include Serenergy A/S, ("SerEnergy") based in Aalborg, Denmark, and fischer eco solutions GmbH, ("FES") based in Achern, Germany. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210625005188/en/ Advent Technologies Enters Into Definitive Agreement to Acquire the Fuel Cell Systems Businesses of fischer Group (Photo: Business Wire) SerEnergy is a leading manufacturer of high-temperature polymer electrolyte membrane (“HT-PEM”) fuel cells globally, with thousands of systems shipped around the globe during its 15-year operation. The company employs 75 people in research and development (“R&D”), production, assembly, and sales, all with unique expertise in the area of

European Datawarehouse Designated as a Securitisation Repository by the European Securities and Markets Authority25.6.2021 13:04:00 EEST | Press release

European DataWarehouse (EDW) today announced it has been designated as a Securitisation Repository by the European Securities and Markets Authority (ESMA). More than three years after the Securitisation Regulation (EU)2017/2402 came into force, and following an extensive application process, the registration of the first Securitisation Repositories closes the final gap in the disclosure framework. In January 2018, European DataWarehouse announced its intention to become a Securitisation Repository under ESMA, and in September 2020 submitted its application. The designation is another milestone in EDW’s almost 10 years of operation as the only Eurosystem designated Securitisation Repository. It is also in line with EDW’s mission to enhance transparency in the securitisation market and demonstrates the company’s strong commitment to delivering market-leading regulatory reporting solutions. In the course of 2021, EDW has worked closely with the reporting entities and provided them with ac

Alvotech Bondholders Convert More Than $100m at Pre-Money Valuation of $2.7bn25.6.2021 12:44:00 EEST | Press release

Alvotech Holdings SA today announced that it has entered into an amendment and restatement agreement with bondholders of its $300m covertible bond issued on December 14, 2018. Bondholders have exercised their conversion rights on approximately one quarter of the value of the bond, converting $106m of principal and accrued interest into equity at an exercise price that gives the company a pre-money valuation of $2.7bn. The company and bondholders also agreed to improve terms on the remaining bond and extend its maturity to 2025, thereby decreasing the company's cost of capital and freeing resources to apply to the execution of its business strategy. Further terms were amended to add additional capital to the company. Robert Wessman, Chairman of Alvotech commented: “With this transaction our stakeholders have reiterated their longstanding confidence in and commitment to our mission: to increase access to the highest quality biologics medicines for patients around the world.” In November

CORRECTING and REPLACING Fibocom FM150-NA 5G Wireless Module Empowers 5G IoT Application in the US with T-Mobile Certification25.6.2021 12:35:00 EEST | Press release

Please replace the release dated May 20, 2021 with the following corrected version due to multiple revisions. The updated release reads: FIBOCOM FM150-NA 5G WIRELESS MODULE EMPOWERS 5G IOT APPLICATION IN THE US WITH T-MOBILE CERTIFICATION Fibocom (Stock Code: 300638), a leading global provider of IoT (Internet of Things) wireless solution and wireless communication modules, today announces that its 5G wireless communication modules FM150-NA has successfully received the T-Mobile Technical Acceptance (TA). The approval signifies that Fibocom FM150-NA 5G module can now provide wireless connection services under T-Mobile’s network, which is an important achievement of the product's entry into the US market. Based on Qualcomm SDX55 chipset platform, Fibocom’s FM150-NA module supports 5G NR Sub-6 band and is backward compatible with LTE and WCDMA network standards. Supporting 5G standalone network (SA) and non-standalone (NSA) network architectures, FM150-NA eliminates customers' investment

Cambridge University Spin-out Lucida Medical Joins GE Healthcare Edison™ Accelerator Programme25.6.2021 10:00:00 EEST | Press release

Cambridge start-up Lucida Medical has today announced that it has joined the Edison Accelerator, a programme designed by GE Healthcare in partnership with innovation organisation Wayra UK, to support early-stage and technologically advanced businesses developing AI applications for healthcare. Participation in the Edison Accelerator programme is a major advance towards Lucida Medical’s goal to disrupt the cancer diagnostic pathway with technology that finds prostate cancer more accurately by analysing MRI, enabling radiologists to save time and patients to receive the best possible diagnosis and treatment. Prostate cancer is the most common cancer in men in Europe, Africa and North and South America, with 1.4 million diagnosed worldwide each year and 375,000 deaths. Earlier and better detection saves lives. The Edison Accelerator creates a collaborative environment for start-ups, research centres, hospitals, clinicians and large corporations across the EMEA region. It aims to foster op

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom